http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015014315-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f1f8f8635438ba45ef1b082d4afd2cc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3765f7bb944599ad4f6d4f6fe5150afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9e8b28149b018c0998e204776a95fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7afb42770c9d1dbd20c747cfde4111ae
publicationDate 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015014315-A1
titleOfInvention Inhibitor crystalline form and preparation method and use thereof
abstract The present invention relates to a new crystalline form of the inhibitor 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; the new crystalline form, as compared to known forms, has one or more improved properties. The present invention also relates to a method for preparing a new crystalline form of 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino) -propyl]-3H-quinazolin-4-one, a pharmaceutical composition thereof, and a use thereof in preparation of a pharmaceutical for the treatment and/or prevention of diseases such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016147206-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017175184-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016157136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106565716-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105712996-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017093773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106565716-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3272751-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105919957-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016188506-A1
priorityDate 2013-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005113556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013134288-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91460914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127361232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322120911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248741479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127374542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246984487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326149178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327879874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248229043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242955549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247898873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226689936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322675575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326686851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325926617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324943131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11625818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327375177

Total number of triples: 50.